Loading…

P037 Nonclinical pharmacokinetics and absorption, distribution, metabolism, and excretion properties of MORF-057 support its clinical development as an oral selective α4β7 integrin inhibitor

Saved in:

Bibliographic Details
Published in:	Journal of Crohn's and colitis 2021-05, Vol.15 (Supplement_1), p.S149-S150
Main Authors:	Jones, J, Lee, D, Smukste, I, Cui, D, Bursavich, M G, Troast, D, Zhong, C, Wong, J E, Mangada, M M, Bain, G, Lippa, B, Ray, A S, Rogers, B N
Format:	Article
Language:	English
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!